F E von Eyben1, M Z Siddiqui, S Thunold
1Department of Oncology, Tawan Hospital, Al Ain, Abu Dhabi, United Arab Emirates.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
High-dose cisplatin may improve remission duration for ovarian germ cell tumors. This case study suggests a potential dose-response relationship, offering hope for advanced stage IV disease.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: